LigronBio
LigronBio is a biotechnology company specializing in the development of molecular glues to target previously inaccessible proteins, aiming to revolutionize targeted protein degradation. Their proprietary AI-powered TriMatrix Analyzer™ platform, combined with computational chemistry, machine learning, and experimental data, accelerates the design and discovery of these novel therapies. The company focuses on addressing unmet medical needs in areas such as cancer and neurological disorders. LigronBio emphasizes its role as a full-service biotech partner, supporting collaborators from early-stage research through clinical trials.
LigronBio
LigronBio is a biotechnology company specializing in the development of molecular glues to target previously inaccessible proteins, aiming to revolutionize targeted protein degradation. Their proprietary AI-powered TriMatrix Analyzer™ platform, combined with computational chemistry, machine learning, and experimental data, accelerates the design and discovery of these novel therapies. The company focuses on addressing unmet medical needs in areas such as cancer and neurological disorders. LigronBio emphasizes its role as a full-service biotech partner, supporting collaborators from early-stage research through clinical trials.